关于安慰剂的争论指向了一个充满诸多灰色地带的问题。
Debate about placebos points to issue surrounded by many shades of grey.
作者信息
Baer N
出版信息
CMAJ. 1996 Nov 15;155(10):1475-6.
Abstract
Dr. Kenneth Rothman, a critic of the use of placebos in clinical trials, recently discussed the issue with Health Canada employees. Some researchers insist this is not a black-and-white issue, and that in some cases patients who receive a placebo are the lucky ones.
摘要
临床试验中使用安慰剂的批评者肯尼斯·罗斯曼博士最近与加拿大卫生部的工作人员讨论了这个问题。一些研究人员坚称这不是一个非黑即白的问题，而且在某些情况下，接受安慰剂的患者是幸运的。
相似文献
1
Debate about placebos points to issue surrounded by many shades of grey.关于安慰剂的争论指向了一个充满诸多灰色地带的问题。
CMAJ. 1996 Nov 15;155(10):1475-6.
2
Placebo orthodoxy in clinical research. II: Ethical, legal, and regulatory myths.临床研究中的安慰剂正统观念。II：伦理、法律及监管方面的误区
J Law Med Ethics. 1996 Fall;24(3):252-9. doi: 10.1111/j.1748-720x.1996.tb01860.x.
3
4
The paradoxical case of payment as benefit to research subjects.将支付作为对研究对象的益处这一矛盾案例。
IRB. 1989 Nov-Dec;11(6):1-3.
5
Forum on prisoners' access to clinical trials: summary of recommendations.囚犯参与临床试验论坛：建议摘要
AIDS Public Policy J. 1996 Spring;11(1):3-20.
6
The changing clinical trials scene: the role of the IRB.不断变化的临床试验场景：机构审查委员会的作用。
IRB. 1988 Jul-Aug;10(4):1-5.
7
An integration of ethical and clinical considerations in the use of placebos.
Psychopharmacol Bull. 1988;24(1):18-20.
8
Placebo controls are not good science.安慰剂对照并非严谨的科学方法。
IRB. 1996 Sep-Oct;18(5):8-10.
9
Dilemmas in the use of active control groups in clinical research.
IRB. 1989 Jan-Feb;11(1):1-5.
10
The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.机构审查委员会在评估非国立卫生研究院资助的临床试验的可推广性方面的作用。
IRB. 1998 Mar-Jun;20(2-3):1-5.
引用本文的文献
1
Ethics in clinical research: searching for absolutes.临床研究中的伦理：探寻绝对准则。
CMAJ. 1998 May 19;158(10):1303-5.
Zotero 插件